Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug

NCT02064634 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02064634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02064634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug
Lead sponsor
Green Cross Corporation
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2014
Completion date
December 31, 2016
Enrollment
6,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis